ARSENA, H.; MUNIR, S. M. Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Bioscientia Medicina : Journal of Biomedicine and Translational Research, v. 10, n. 7, p. 2624-2636, 12 Jun. 2026.